KR20240004857A - 우울증 치료를 위한 조성물 및 방법 - Google Patents

우울증 치료를 위한 조성물 및 방법 Download PDF

Info

Publication number
KR20240004857A
KR20240004857A KR1020237041546A KR20237041546A KR20240004857A KR 20240004857 A KR20240004857 A KR 20240004857A KR 1020237041546 A KR1020237041546 A KR 1020237041546A KR 20237041546 A KR20237041546 A KR 20237041546A KR 20240004857 A KR20240004857 A KR 20240004857A
Authority
KR
South Korea
Prior art keywords
articarant
patient
anhedonia
treatment
baseline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237041546A
Other languages
English (en)
Korean (ko)
Inventor
마크 슈미트
바니나 포포바
아담 사비츠
라마 멜코트
웨인 씨. 드리베츠
스리하리 고팔
데럴 펨버튼
차크라드하르 라기셰티
이바 케직
Original Assignee
얀센 파마슈티칼즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/307,858 external-priority patent/US11266627B1/en
Priority claimed from US17/670,123 external-priority patent/US12161622B2/en
Application filed by 얀센 파마슈티칼즈, 인코포레이티드 filed Critical 얀센 파마슈티칼즈, 인코포레이티드
Publication of KR20240004857A publication Critical patent/KR20240004857A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
KR1020237041546A 2021-05-04 2022-05-03 우울증 치료를 위한 조성물 및 방법 Pending KR20240004857A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US17/307,858 2021-05-04
US17/307,858 US11266627B1 (en) 2021-05-04 2021-05-04 Compositions and methods for the treatment of depression
US17/670,123 2022-02-11
US17/670,123 US12161622B2 (en) 2021-05-04 2022-02-11 Compositions and methods for the treatment of depression
US202263313792P 2022-02-25 2022-02-25
US63/313,792 2022-02-25
PCT/IB2022/054085 WO2022234457A1 (en) 2021-05-04 2022-05-03 Compositions and methods for the treatment of depression

Publications (1)

Publication Number Publication Date
KR20240004857A true KR20240004857A (ko) 2024-01-11

Family

ID=81654924

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237041546A Pending KR20240004857A (ko) 2021-05-04 2022-05-03 우울증 치료를 위한 조성물 및 방법

Country Status (16)

Country Link
EP (1) EP4333835A1 (https=)
JP (1) JP2024516297A (https=)
KR (1) KR20240004857A (https=)
AU (1) AU2022268720A1 (https=)
BR (1) BR112023023030A2 (https=)
CA (1) CA3219079A1 (https=)
CL (1) CL2023003259A1 (https=)
CO (1) CO2023015571A2 (https=)
IL (1) IL308221A (https=)
JO (1) JOP20230276A1 (https=)
MX (1) MX2023013040A (https=)
PE (1) PE20241784A1 (https=)
PH (1) PH12023552963A1 (https=)
TW (1) TW202313003A (https=)
UY (1) UY39754A (https=)
WO (1) WO2022234457A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
AU2023231493A1 (en) * 2022-03-07 2024-10-24 Janssen Pharmaceuticals, Inc. Pure forms of crystalline aticaprant
WO2023170554A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Compositions comprising aticaprant
WO2023170550A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Polymorph forms of aticaprant for use in treating major depressive disorder
WO2024216046A1 (en) * 2023-04-13 2024-10-17 Neumora Therapeutics, Inc. Methods of treating anhedonia
WO2024216061A1 (en) * 2023-04-13 2024-10-17 Neumora Therapeutics, Inc. Methods of treating depression and anhedonia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5345637B2 (ja) 2008-01-22 2013-11-20 イーライ リリー アンド カンパニー κ選択的オピオイド受容体アンタゴニスト

Also Published As

Publication number Publication date
CO2023015571A2 (es) 2023-11-30
EP4333835A1 (en) 2024-03-13
IL308221A (en) 2024-01-01
CL2023003259A1 (es) 2024-05-31
WO2022234457A1 (en) 2022-11-10
PH12023552963A1 (en) 2024-03-11
PE20241784A1 (es) 2024-09-06
MX2023013040A (es) 2024-01-05
UY39754A (es) 2022-11-30
JP2024516297A (ja) 2024-04-12
AU2022268720A1 (en) 2023-12-21
TW202313003A (zh) 2023-04-01
BR112023023030A2 (pt) 2024-02-15
CA3219079A1 (en) 2022-11-10
JOP20230276A1 (ar) 2023-11-02

Similar Documents

Publication Publication Date Title
KR20240004857A (ko) 우울증 치료를 위한 조성물 및 방법
CN104519878A (zh) 用于治疗顽固性或难治性抑郁症的艾氯胺酮
US12150929B2 (en) Compositions and methods for the treatment of depression
US20240024340A1 (en) Compositions and Methods For Treating Migraine
JP2025508069A (ja) アチカプラントを含む組成物
US20120010242A1 (en) Low dose pipamperone in treating mood disorders
KR20240132479A (ko) 우울증 치료를 위한 조성물 및 방법
US20250177350A1 (en) Compositions and methods for the treatment of depression
US20240238245A1 (en) Compositions and methods for the treatment of depression
CN117615757A (zh) 用于治疗抑郁症的组合物和方法
KR20240132501A (ko) 우울증 치료를 위한 조성물 및 방법
Walitza et al. Psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder (ADHD)
US20240358693A1 (en) Methods of treating pain
EA050800B1 (ru) Композиции и способы лечения депрессии
US12036213B2 (en) Pridopidine for treating drug induced dyskinesias
JP7840873B2 (ja) うつ病の治療方法
Roller et al. Disease state management: Mood disorders: Part one: Depression and antidepressants
WO2012072665A1 (en) Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231201

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250430

Comment text: Request for Examination of Application